Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation-Reference-Cited by-同舟云学术

Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Published:2020-02 Issue:2 Volume:26 Page:262-271
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Hill Brian T.,Rybicki Lisa A.,Urban Theresa A.,Lucena Mariana,Jagadeesh Deepa,Gerds Aaron T.,Dean Robert M.,Sobecks Ronald M.,Pohlman Brad,Bolwell Brian,Kalaycio Matt E.,Hamilton Betty K.,Copelan Edward A.,Majhail Navneet S.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma;Armitage;Eur J Cancer Clin Oncol,1986

2. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma;Philip;N Engl J Med,1987

3. Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation;Vose;Am J Med,1989

4. The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls;Hill;Br J Haematol,2011

5. Survival outcomes of younger patients with mantle cell lymphoma treated in the rituximab era;Gerson;J Clin Oncol,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients;Therapeutic Drug Monitoring;2024-06-14

2. BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation;American Journal of Hematology;2024-03-25

3. Significance of therapeutic dose monitoring of busulfan and targeted dose adjustment in transplantation;Japanese Journal of Transplantation and Cellular Therapy;2023

4. External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients;Frontiers in Pharmacology;2022-07-07

5. Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring;Journal of Oncology Pharmacy Practice;2022-06-07